Similar Papers

Paper Title
Journal
Date
Author
Ado-trastuzumab emtansine: Therapy for metastatic breast cancer
Maria G Tanzi
Pharmacy Today | VOL. 19
Maria G TanziMaria G Tanzi
01 Apr 2013
Abstract P4-21-20: Lapatinib after pertuzumab and ado-trastuzumab emtansine in metastatic HER2-positive breast cancer
L Báez-Vallecillo ... Sl Moulder
Cancer Research | VOL. 77
L Báez-Vallecillo, et. al.L Báez-Vallecillo ... Sl Moulder
14 Feb 2017
Trastuzumab and survival of patients with metastatic breast cancer.
Karin Kast ... Stefanie J Klug
Archives of Gynecology and Obstetrics | VOL. 296
Karin Kast, et. al.Karin Kast ... Stefanie J Klug
14 Jun 2017
Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future
T Robinson ... J.P Braybrooke
Clinical Oncology | VOL. 32
T Robinson, et. al.T Robinson ... J.P Braybrooke
14 May 2020
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Missed Opportunity for Sotorasib Dose Optimization
Garth W Strohbehn ... Mark J Ratain
Journal of Clinical Oncology | VOL. -
Garth W Strohbehn, et. al.Garth W Strohbehn ... Mark J Ratain
06 Feb 2025
Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
Sapna P Patel ... Theresa Medina
Journal of Clinical Oncology | VOL. -
Sapna P Patel, et. al.Sapna P Patel ... Theresa Medina
06 Feb 2025
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.